Michael Lang to Head Product Development for Texas Cancer Agency

Xconomy Texas — 

The Cancer Prevention and Research Institute of Texas has hired a former biotech executive as its new chief product development officer. Michael Lang formerly had leadership positions NanoVision, a Pennsylvania cancer diagnostics company, and Dallas-based Galt Medical, a medical device company. He succeeds Tom Goodman, a former vice president of business development at Arizona Technology Enterprises—the tech transfer arm of Arizona State University and the Arizona Biodesign Institute—who left the agency in June after one year. CPRIT says it has awarded 27 product development grants totally more than $250 million since the agency was founded in 2009.